nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Guanethidine—hypertension	0.0697	0.11	CbGbCtD
Fosamprenavir—CYP3A4—Hydralazine—hypertension	0.0528	0.0837	CbGbCtD
Fosamprenavir—CYP3A4—Guanfacine—hypertension	0.0449	0.0712	CbGbCtD
Fosamprenavir—CYP3A4—Isradipine—hypertension	0.04	0.0634	CbGbCtD
Fosamprenavir—CYP3A4—Indapamide—hypertension	0.0352	0.0559	CbGbCtD
Fosamprenavir—CYP3A4—Nisoldipine—hypertension	0.0352	0.0559	CbGbCtD
Fosamprenavir—CYP3A4—Diltiazem—hypertension	0.034	0.0539	CbGbCtD
Fosamprenavir—CYP3A4—Eplerenone—hypertension	0.034	0.0539	CbGbCtD
Fosamprenavir—CYP3A4—Enalapril—hypertension	0.0303	0.0481	CbGbCtD
Fosamprenavir—CYP3A4—Irbesartan—hypertension	0.0277	0.044	CbGbCtD
Fosamprenavir—CYP3A4—Amlodipine—hypertension	0.0272	0.0431	CbGbCtD
Fosamprenavir—CYP3A4—Felodipine—hypertension	0.0262	0.0416	CbGbCtD
Fosamprenavir—CYP3A4—Nifedipine—hypertension	0.0254	0.0402	CbGbCtD
Fosamprenavir—CYP3A4—Nicardipine—hypertension	0.025	0.0396	CbGbCtD
Fosamprenavir—CYP3A4—Carvedilol—hypertension	0.025	0.0396	CbGbCtD
Fosamprenavir—CYP3A4—Propranolol—hypertension	0.023	0.0364	CbGbCtD
Fosamprenavir—CYP3A4—Clonidine—hypertension	0.0219	0.0348	CbGbCtD
Fosamprenavir—CYP3A4—Atorvastatin—hypertension	0.0195	0.031	CbGbCtD
Fosamprenavir—CYP3A4—Losartan—hypertension	0.0179	0.0283	CbGbCtD
Fosamprenavir—CYP3A4—Verapamil—hypertension	0.0158	0.025	CbGbCtD
Fosamprenavir—Amprenavir—ABCC1—hypertension	0.00329	0.622	CrCbGaD
Fosamprenavir—Amprenavir—CYP3A5—hypertension	0.002	0.378	CrCbGaD
Fosamprenavir—CYP3A4—Aflatoxin B1 metabolism—EPHX1—hypertension	0.000723	0.0552	CbGpPWpGaD
Fosamprenavir—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—hypertension	0.000592	0.0452	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—AOC1—hypertension	0.000433	0.0331	CbGpPWpGaD
Fosamprenavir—CYP3A4—Irinotecan Pathway—CYP3A5—hypertension	0.000326	0.0249	CbGpPWpGaD
Fosamprenavir—CYP3A4—Irinotecan Pathway—ABCC1—hypertension	0.000315	0.024	CbGpPWpGaD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—CYP4A11—hypertension	0.000304	0.0232	CbGpPWpGaD
Fosamprenavir—CYP3A4—Xenobiotics—CYP2J2—hypertension	0.000303	0.0231	CbGpPWpGaD
Fosamprenavir—CYP3A4—Estrogen metabolism—STS—hypertension	0.000289	0.0221	CbGpPWpGaD
Fosamprenavir—CYP3A4—Aflatoxin activation and detoxification—CYP3A5—hypertension	0.000255	0.0195	CbGpPWpGaD
Fosamprenavir—CYP3A4—Xenobiotics—CYP3A5—hypertension	0.000245	0.0187	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tamoxifen metabolism—CYP3A5—hypertension	0.000236	0.018	CbGpPWpGaD
Fosamprenavir—CYP3A4—Aflatoxin B1 metabolism—GSTM1—hypertension	0.00023	0.0176	CbGpPWpGaD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—hypertension	0.000196	0.015	CbGpPWpGaD
Fosamprenavir—CYP3A4—Xenobiotics—CYP2C18—hypertension	0.000193	0.0147	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—CYP4F12—hypertension	0.00018	0.0137	CbGpPWpGaD
Fosamprenavir—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—hypertension	0.000179	0.0136	CbGpPWpGaD
Fosamprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—CYP4A11—hypertension	0.000175	0.0133	CbGpPWpGaD
Fosamprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—CYP3A5—hypertension	0.000168	0.0128	CbGpPWpGaD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4A11—hypertension	0.000167	0.0127	CbGpPWpGaD
Fosamprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—ALAS1—hypertension	0.000157	0.012	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—CYP2J2—hypertension	0.000155	0.0119	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4F12—hypertension	0.000146	0.0111	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP4F12—hypertension	0.000144	0.011	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B1—hypertension	0.000134	0.0103	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP11B1—hypertension	0.000133	0.0101	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2J2—hypertension	0.000126	0.00959	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP2J2—hypertension	0.000124	0.00946	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—TPH1—hypertension	0.000122	0.00928	CbGpPWpGaD
Fosamprenavir—Asthenia—Olmesartan—hypertension	0.000119	0.00034	CcSEcCtD
Fosamprenavir—Dizziness—Nifedipine—hypertension	0.000119	0.00034	CcSEcCtD
Fosamprenavir—Rash—Indapamide—hypertension	0.000119	0.000339	CcSEcCtD
Fosamprenavir—Rash—Diltiazem—hypertension	0.000119	0.000339	CcSEcCtD
Fosamprenavir—Dermatitis—Indapamide—hypertension	0.000119	0.000339	CcSEcCtD
Fosamprenavir—Dermatitis—Diltiazem—hypertension	0.000119	0.000339	CcSEcCtD
Fosamprenavir—Vomiting—Carvedilol—hypertension	0.000119	0.000339	CcSEcCtD
Fosamprenavir—Dizziness—Verapamil—hypertension	0.000119	0.000338	CcSEcCtD
Fosamprenavir—CYP3A4—Estrogen metabolism—COMT—hypertension	0.000118	0.00903	CbGpPWpGaD
Fosamprenavir—Headache—Indapamide—hypertension	0.000118	0.000337	CcSEcCtD
Fosamprenavir—Headache—Diltiazem—hypertension	0.000118	0.000337	CcSEcCtD
Fosamprenavir—Pruritus—Valsartan—hypertension	0.000118	0.000337	CcSEcCtD
Fosamprenavir—Myalgia—Timolol—hypertension	0.000118	0.000337	CcSEcCtD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP4F12—hypertension	0.000118	0.00901	CbGpPWpGaD
Fosamprenavir—Rash—Carvedilol—hypertension	0.000118	0.000336	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Perindopril—hypertension	0.000118	0.000336	CcSEcCtD
Fosamprenavir—Dermatitis—Carvedilol—hypertension	0.000118	0.000336	CcSEcCtD
Fosamprenavir—Angioedema—Lisinopril—hypertension	0.000118	0.000335	CcSEcCtD
Fosamprenavir—Pruritus—Olmesartan—hypertension	0.000118	0.000335	CcSEcCtD
Fosamprenavir—Vomiting—Doxazosin—hypertension	0.000117	0.000335	CcSEcCtD
Fosamprenavir—Decreased appetite—Losartan—hypertension	0.000117	0.000335	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Irbesartan—hypertension	0.000117	0.000335	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	0.000117	0.000334	CcSEcCtD
Fosamprenavir—Hypersensitivity—Clonidine—hypertension	0.000117	0.000334	CcSEcCtD
Fosamprenavir—Abdominal pain—Captopril—hypertension	0.000117	0.000334	CcSEcCtD
Fosamprenavir—Body temperature increased—Captopril—hypertension	0.000117	0.000334	CcSEcCtD
Fosamprenavir—Headache—Carvedilol—hypertension	0.000117	0.000334	CcSEcCtD
Fosamprenavir—Rash—Doxazosin—hypertension	0.000116	0.000332	CcSEcCtD
Fosamprenavir—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—hypertension	0.000116	0.00888	CbGpPWpGaD
Fosamprenavir—Fatigue—Losartan—hypertension	0.000116	0.000332	CcSEcCtD
Fosamprenavir—Dermatitis—Doxazosin—hypertension	0.000116	0.000332	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Hydrochlorothiazide—hypertension	0.000116	0.000332	CcSEcCtD
Fosamprenavir—Vomiting—Fosinopril—hypertension	0.000116	0.000331	CcSEcCtD
Fosamprenavir—Nausea—Propranolol—hypertension	0.000116	0.00033	CcSEcCtD
Fosamprenavir—Headache—Doxazosin—hypertension	0.000116	0.00033	CcSEcCtD
Fosamprenavir—Vomiting—Eplerenone—hypertension	0.000115	0.000329	CcSEcCtD
Fosamprenavir—Rash—Fosinopril—hypertension	0.000115	0.000328	CcSEcCtD
Fosamprenavir—Dermatitis—Fosinopril—hypertension	0.000115	0.000328	CcSEcCtD
Fosamprenavir—Vomiting—Nifedipine—hypertension	0.000114	0.000327	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Furosemide—hypertension	0.000114	0.000326	CcSEcCtD
Fosamprenavir—Rash—Eplerenone—hypertension	0.000114	0.000326	CcSEcCtD
Fosamprenavir—Headache—Fosinopril—hypertension	0.000114	0.000326	CcSEcCtD
Fosamprenavir—Hypersensitivity—Trandolapril—hypertension	0.000114	0.000326	CcSEcCtD
Fosamprenavir—Dermatitis—Eplerenone—hypertension	0.000114	0.000326	CcSEcCtD
Fosamprenavir—Diarrhoea—Valsartan—hypertension	0.000114	0.000326	CcSEcCtD
Fosamprenavir—Asthenia—Clonidine—hypertension	0.000114	0.000326	CcSEcCtD
Fosamprenavir—Vomiting—Verapamil—hypertension	0.000114	0.000325	CcSEcCtD
Fosamprenavir—Hypersensitivity—Enalapril—hypertension	0.000114	0.000325	CcSEcCtD
Fosamprenavir—Abdominal pain—Perindopril—hypertension	0.000114	0.000324	CcSEcCtD
Fosamprenavir—Body temperature increased—Perindopril—hypertension	0.000114	0.000324	CcSEcCtD
Fosamprenavir—Diarrhoea—Olmesartan—hypertension	0.000114	0.000324	CcSEcCtD
Fosamprenavir—Headache—Eplerenone—hypertension	0.000114	0.000324	CcSEcCtD
Fosamprenavir—Rash—Nifedipine—hypertension	0.000114	0.000324	CcSEcCtD
Fosamprenavir—Nervous system disorder—Ramipril—hypertension	0.000114	0.000324	CcSEcCtD
Fosamprenavir—Dermatitis—Nifedipine—hypertension	0.000113	0.000323	CcSEcCtD
Fosamprenavir—Body temperature increased—Irbesartan—hypertension	0.000113	0.000323	CcSEcCtD
Fosamprenavir—Abdominal pain—Irbesartan—hypertension	0.000113	0.000323	CcSEcCtD
Fosamprenavir—Rash—Verapamil—hypertension	0.000113	0.000322	CcSEcCtD
Fosamprenavir—Dermatitis—Verapamil—hypertension	0.000113	0.000322	CcSEcCtD
Fosamprenavir—Headache—Nifedipine—hypertension	0.000113	0.000322	CcSEcCtD
Fosamprenavir—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—hypertension	0.000113	0.0086	CbGpPWpGaD
Fosamprenavir—Pruritus—Clonidine—hypertension	0.000113	0.000321	CcSEcCtD
Fosamprenavir—Body temperature increased—Hydrochlorothiazide—hypertension	0.000112	0.000321	CcSEcCtD
Fosamprenavir—Abdominal pain—Hydrochlorothiazide—hypertension	0.000112	0.000321	CcSEcCtD
Fosamprenavir—Skin disorder—Ramipril—hypertension	0.000112	0.000321	CcSEcCtD
Fosamprenavir—Headache—Verapamil—hypertension	0.000112	0.00032	CcSEcCtD
Fosamprenavir—Hypersensitivity—Telmisartan—hypertension	0.000112	0.00032	CcSEcCtD
Fosamprenavir—Nausea—Diltiazem—hypertension	0.000112	0.00032	CcSEcCtD
Fosamprenavir—Nausea—Indapamide—hypertension	0.000112	0.00032	CcSEcCtD
Fosamprenavir—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—hypertension	0.000112	0.00852	CbGpPWpGaD
Fosamprenavir—Asthenia—Trandolapril—hypertension	0.000111	0.000318	CcSEcCtD
Fosamprenavir—Nervous system disorder—Timolol—hypertension	0.000111	0.000316	CcSEcCtD
Fosamprenavir—Nausea—Carvedilol—hypertension	0.000111	0.000316	CcSEcCtD
Fosamprenavir—Asthenia—Enalapril—hypertension	0.000111	0.000316	CcSEcCtD
Fosamprenavir—Body temperature increased—Furosemide—hypertension	0.000111	0.000315	CcSEcCtD
Fosamprenavir—Abdominal pain—Furosemide—hypertension	0.000111	0.000315	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Losartan—hypertension	0.00011	0.000315	CcSEcCtD
Fosamprenavir—Dizziness—Valsartan—hypertension	0.00011	0.000315	CcSEcCtD
Fosamprenavir—Anorexia—Ramipril—hypertension	0.00011	0.000315	CcSEcCtD
Fosamprenavir—Skin disorder—Timolol—hypertension	0.00011	0.000313	CcSEcCtD
Fosamprenavir—Dizziness—Olmesartan—hypertension	0.00011	0.000313	CcSEcCtD
Fosamprenavir—Pruritus—Trandolapril—hypertension	0.00011	0.000313	CcSEcCtD
Fosamprenavir—Nausea—Doxazosin—hypertension	0.00011	0.000313	CcSEcCtD
Fosamprenavir—Myalgia—Lisinopril—hypertension	0.00011	0.000312	CcSEcCtD
Fosamprenavir—Body temperature increased—Betaxolol—hypertension	0.000109	0.000312	CcSEcCtD
Fosamprenavir—Asthenia—Telmisartan—hypertension	0.000109	0.000312	CcSEcCtD
Fosamprenavir—Pruritus—Enalapril—hypertension	0.000109	0.000312	CcSEcCtD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B1—hypertension	0.000109	0.00831	CbGpPWpGaD
Fosamprenavir—Diarrhoea—Clonidine—hypertension	0.000109	0.00031	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	0.000109	0.00031	CcSEcCtD
Fosamprenavir—Nausea—Fosinopril—hypertension	0.000108	0.000309	CcSEcCtD
Fosamprenavir—CYP3A4—Estrogen metabolism—GSTM1—hypertension	0.000108	0.00826	CbGpPWpGaD
Fosamprenavir—Anorexia—Timolol—hypertension	0.000108	0.000308	CcSEcCtD
Fosamprenavir—Pruritus—Telmisartan—hypertension	0.000108	0.000308	CcSEcCtD
Fosamprenavir—Nausea—Eplerenone—hypertension	0.000108	0.000307	CcSEcCtD
Fosamprenavir—Nausea—Nifedipine—hypertension	0.000107	0.000305	CcSEcCtD
Fosamprenavir—Abdominal pain—Losartan—hypertension	0.000107	0.000304	CcSEcCtD
Fosamprenavir—Body temperature increased—Losartan—hypertension	0.000107	0.000304	CcSEcCtD
Fosamprenavir—Nausea—Verapamil—hypertension	0.000106	0.000304	CcSEcCtD
Fosamprenavir—Asthenia—Captopril—hypertension	0.000106	0.000303	CcSEcCtD
Fosamprenavir—Diarrhoea—Trandolapril—hypertension	0.000106	0.000303	CcSEcCtD
Fosamprenavir—Vomiting—Valsartan—hypertension	0.000106	0.000303	CcSEcCtD
Fosamprenavir—Diarrhoea—Enalapril—hypertension	0.000106	0.000302	CcSEcCtD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4A11—hypertension	0.000106	0.00807	CbGpPWpGaD
Fosamprenavir—Hypersensitivity—Irbesartan—hypertension	0.000106	0.000301	CcSEcCtD
Fosamprenavir—Vomiting—Olmesartan—hypertension	0.000106	0.000301	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Ramipril—hypertension	0.000105	0.000301	CcSEcCtD
Fosamprenavir—Rash—Valsartan—hypertension	0.000105	0.0003	CcSEcCtD
Fosamprenavir—Dizziness—Clonidine—hypertension	0.000105	0.0003	CcSEcCtD
Fosamprenavir—Dermatitis—Valsartan—hypertension	0.000105	0.0003	CcSEcCtD
Fosamprenavir—Pruritus—Captopril—hypertension	0.000105	0.000299	CcSEcCtD
Fosamprenavir—Hypersensitivity—Hydrochlorothiazide—hypertension	0.000105	0.000299	CcSEcCtD
Fosamprenavir—Rash—Olmesartan—hypertension	0.000105	0.000299	CcSEcCtD
Fosamprenavir—Dermatitis—Olmesartan—hypertension	0.000105	0.000298	CcSEcCtD
Fosamprenavir—Headache—Valsartan—hypertension	0.000105	0.000298	CcSEcCtD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP4A11—hypertension	0.000104	0.00797	CbGpPWpGaD
Fosamprenavir—Diarrhoea—Telmisartan—hypertension	0.000104	0.000297	CcSEcCtD
Fosamprenavir—Headache—Olmesartan—hypertension	0.000104	0.000297	CcSEcCtD
Fosamprenavir—Asthenia—Perindopril—hypertension	0.000103	0.000294	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Timolol—hypertension	0.000103	0.000294	CcSEcCtD
Fosamprenavir—Hypersensitivity—Furosemide—hypertension	0.000103	0.000294	CcSEcCtD
Fosamprenavir—Asthenia—Irbesartan—hypertension	0.000103	0.000294	CcSEcCtD
Fosamprenavir—Dizziness—Trandolapril—hypertension	0.000103	0.000293	CcSEcCtD
Fosamprenavir—CYP3A4—Estrogen metabolism—CYP1A1—hypertension	0.000103	0.00783	CbGpPWpGaD
Fosamprenavir—Dizziness—Enalapril—hypertension	0.000102	0.000291	CcSEcCtD
Fosamprenavir—Asthenia—Hydrochlorothiazide—hypertension	0.000102	0.000291	CcSEcCtD
Fosamprenavir—Hypersensitivity—Betaxolol—hypertension	0.000102	0.000291	CcSEcCtD
Fosamprenavir—Skin disorder—Lisinopril—hypertension	0.000102	0.000291	CcSEcCtD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2J2—hypertension	0.000102	0.00777	CbGpPWpGaD
Fosamprenavir—Pruritus—Perindopril—hypertension	0.000102	0.00029	CcSEcCtD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—PTGIS—hypertension	0.000102	0.00777	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A5—hypertension	0.000102	0.00777	CbGpPWpGaD
Fosamprenavir—Pruritus—Irbesartan—hypertension	0.000101	0.000289	CcSEcCtD
Fosamprenavir—Diarrhoea—Captopril—hypertension	0.000101	0.000289	CcSEcCtD
Fosamprenavir—Vomiting—Clonidine—hypertension	0.000101	0.000289	CcSEcCtD
Fosamprenavir—Dizziness—Telmisartan—hypertension	0.000101	0.000287	CcSEcCtD
Fosamprenavir—Pruritus—Hydrochlorothiazide—hypertension	0.000101	0.000287	CcSEcCtD
Fosamprenavir—Decreased appetite—Ramipril—hypertension	0.000101	0.000287	CcSEcCtD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP3A5—hypertension	0.0001	0.00767	CbGpPWpGaD
Fosamprenavir—Asthenia—Furosemide—hypertension	0.0001	0.000286	CcSEcCtD
Fosamprenavir—Rash—Clonidine—hypertension	0.0001	0.000286	CcSEcCtD
Fosamprenavir—Dermatitis—Clonidine—hypertension	0.0001	0.000286	CcSEcCtD
Fosamprenavir—Anorexia—Lisinopril—hypertension	0.0001	0.000285	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Ramipril—hypertension	9.99e-05	0.000285	CcSEcCtD
Fosamprenavir—Fatigue—Ramipril—hypertension	9.98e-05	0.000285	CcSEcCtD
Fosamprenavir—Headache—Clonidine—hypertension	9.97e-05	0.000284	CcSEcCtD
Fosamprenavir—Hypersensitivity—Losartan—hypertension	9.95e-05	0.000284	CcSEcCtD
Fosamprenavir—Asthenia—Betaxolol—hypertension	9.94e-05	0.000283	CcSEcCtD
Fosamprenavir—Nausea—Valsartan—hypertension	9.91e-05	0.000283	CcSEcCtD
Fosamprenavir—CYP3A4—Tryptophan metabolism—CYP2C18—hypertension	9.91e-05	0.00757	CbGpPWpGaD
Fosamprenavir—Pruritus—Furosemide—hypertension	9.9e-05	0.000282	CcSEcCtD
Fosamprenavir—Nausea—Olmesartan—hypertension	9.87e-05	0.000281	CcSEcCtD
Fosamprenavir—Vomiting—Trandolapril—hypertension	9.87e-05	0.000281	CcSEcCtD
Fosamprenavir—Diarrhoea—Perindopril—hypertension	9.85e-05	0.000281	CcSEcCtD
Fosamprenavir—Decreased appetite—Timolol—hypertension	9.84e-05	0.000281	CcSEcCtD
Fosamprenavir—Vomiting—Enalapril—hypertension	9.83e-05	0.00028	CcSEcCtD
Fosamprenavir—Diarrhoea—Irbesartan—hypertension	9.81e-05	0.00028	CcSEcCtD
Fosamprenavir—Dizziness—Captopril—hypertension	9.8e-05	0.00028	CcSEcCtD
Fosamprenavir—Pruritus—Betaxolol—hypertension	9.8e-05	0.000279	CcSEcCtD
Fosamprenavir—Rash—Trandolapril—hypertension	9.78e-05	0.000279	CcSEcCtD
Fosamprenavir—Dermatitis—Trandolapril—hypertension	9.77e-05	0.000279	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Timolol—hypertension	9.77e-05	0.000279	CcSEcCtD
Fosamprenavir—Fatigue—Timolol—hypertension	9.76e-05	0.000278	CcSEcCtD
Fosamprenavir—Rash—Enalapril—hypertension	9.74e-05	0.000278	CcSEcCtD
Fosamprenavir—Dermatitis—Enalapril—hypertension	9.74e-05	0.000278	CcSEcCtD
Fosamprenavir—Diarrhoea—Hydrochlorothiazide—hypertension	9.73e-05	0.000278	CcSEcCtD
Fosamprenavir—Headache—Trandolapril—hypertension	9.72e-05	0.000277	CcSEcCtD
Fosamprenavir—Vomiting—Telmisartan—hypertension	9.69e-05	0.000276	CcSEcCtD
Fosamprenavir—Asthenia—Losartan—hypertension	9.69e-05	0.000276	CcSEcCtD
Fosamprenavir—Headache—Enalapril—hypertension	9.68e-05	0.000276	CcSEcCtD
Fosamprenavir—Rash—Telmisartan—hypertension	9.61e-05	0.000274	CcSEcCtD
Fosamprenavir—Dermatitis—Telmisartan—hypertension	9.6e-05	0.000274	CcSEcCtD
Fosamprenavir—Diarrhoea—Furosemide—hypertension	9.57e-05	0.000273	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Lisinopril—hypertension	9.56e-05	0.000273	CcSEcCtD
Fosamprenavir—Pruritus—Losartan—hypertension	9.55e-05	0.000272	CcSEcCtD
Fosamprenavir—Headache—Telmisartan—hypertension	9.55e-05	0.000272	CcSEcCtD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B2—hypertension	9.52e-05	0.00727	CbGpPWpGaD
Fosamprenavir—Dizziness—Perindopril—hypertension	9.52e-05	0.000271	CcSEcCtD
Fosamprenavir—Dizziness—Irbesartan—hypertension	9.49e-05	0.000271	CcSEcCtD
Fosamprenavir—Diarrhoea—Betaxolol—hypertension	9.48e-05	0.00027	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Ramipril—hypertension	9.46e-05	0.00027	CcSEcCtD
Fosamprenavir—Nausea—Clonidine—hypertension	9.45e-05	0.00027	CcSEcCtD
Fosamprenavir—CYP3A4—Xenobiotics—CYP1A1—hypertension	9.42e-05	0.00719	CbGpPWpGaD
Fosamprenavir—Vomiting—Captopril—hypertension	9.42e-05	0.000269	CcSEcCtD
Fosamprenavir—Dizziness—Hydrochlorothiazide—hypertension	9.41e-05	0.000268	CcSEcCtD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP11B2—hypertension	9.4e-05	0.00717	CbGpPWpGaD
Fosamprenavir—Rash—Captopril—hypertension	9.35e-05	0.000267	CcSEcCtD
Fosamprenavir—Dermatitis—Captopril—hypertension	9.34e-05	0.000266	CcSEcCtD
Fosamprenavir—Headache—Captopril—hypertension	9.29e-05	0.000265	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Timolol—hypertension	9.25e-05	0.000264	CcSEcCtD
Fosamprenavir—Dizziness—Furosemide—hypertension	9.25e-05	0.000264	CcSEcCtD
Fosamprenavir—Diarrhoea—Losartan—hypertension	9.24e-05	0.000263	CcSEcCtD
Fosamprenavir—Nausea—Trandolapril—hypertension	9.22e-05	0.000263	CcSEcCtD
Fosamprenavir—Nausea—Enalapril—hypertension	9.18e-05	0.000262	CcSEcCtD
Fosamprenavir—Dizziness—Betaxolol—hypertension	9.16e-05	0.000261	CcSEcCtD
Fosamprenavir—Vomiting—Perindopril—hypertension	9.15e-05	0.000261	CcSEcCtD
Fosamprenavir—Body temperature increased—Ramipril—hypertension	9.15e-05	0.000261	CcSEcCtD
Fosamprenavir—Abdominal pain—Ramipril—hypertension	9.15e-05	0.000261	CcSEcCtD
Fosamprenavir—Decreased appetite—Lisinopril—hypertension	9.13e-05	0.00026	CcSEcCtD
Fosamprenavir—Vomiting—Irbesartan—hypertension	9.12e-05	0.00026	CcSEcCtD
Fosamprenavir—Rash—Perindopril—hypertension	9.07e-05	0.000259	CcSEcCtD
Fosamprenavir—Dermatitis—Perindopril—hypertension	9.07e-05	0.000259	CcSEcCtD
Fosamprenavir—CYP3A4—Tamoxifen metabolism—CYP1A1—hypertension	9.06e-05	0.00692	CbGpPWpGaD
Fosamprenavir—Gastrointestinal disorder—Lisinopril—hypertension	9.06e-05	0.000258	CcSEcCtD
Fosamprenavir—Nausea—Telmisartan—hypertension	9.05e-05	0.000258	CcSEcCtD
Fosamprenavir—Fatigue—Lisinopril—hypertension	9.05e-05	0.000258	CcSEcCtD
Fosamprenavir—Vomiting—Hydrochlorothiazide—hypertension	9.05e-05	0.000258	CcSEcCtD
Fosamprenavir—Rash—Irbesartan—hypertension	9.04e-05	0.000258	CcSEcCtD
Fosamprenavir—Dermatitis—Irbesartan—hypertension	9.04e-05	0.000258	CcSEcCtD
Fosamprenavir—Headache—Perindopril—hypertension	9.02e-05	0.000257	CcSEcCtD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—hypertension	8.99e-05	0.00686	CbGpPWpGaD
Fosamprenavir—Headache—Irbesartan—hypertension	8.99e-05	0.000256	CcSEcCtD
Fosamprenavir—Rash—Hydrochlorothiazide—hypertension	8.97e-05	0.000256	CcSEcCtD
Fosamprenavir—Dermatitis—Hydrochlorothiazide—hypertension	8.96e-05	0.000256	CcSEcCtD
Fosamprenavir—Abdominal pain—Timolol—hypertension	8.95e-05	0.000255	CcSEcCtD
Fosamprenavir—Body temperature increased—Timolol—hypertension	8.95e-05	0.000255	CcSEcCtD
Fosamprenavir—Dizziness—Losartan—hypertension	8.93e-05	0.000255	CcSEcCtD
Fosamprenavir—Headache—Hydrochlorothiazide—hypertension	8.91e-05	0.000254	CcSEcCtD
Fosamprenavir—Vomiting—Furosemide—hypertension	8.9e-05	0.000254	CcSEcCtD
Fosamprenavir—Rash—Furosemide—hypertension	8.82e-05	0.000252	CcSEcCtD
Fosamprenavir—Dermatitis—Furosemide—hypertension	8.81e-05	0.000251	CcSEcCtD
Fosamprenavir—Vomiting—Betaxolol—hypertension	8.81e-05	0.000251	CcSEcCtD
Fosamprenavir—Nausea—Captopril—hypertension	8.8e-05	0.000251	CcSEcCtD
Fosamprenavir—Headache—Furosemide—hypertension	8.76e-05	0.00025	CcSEcCtD
Fosamprenavir—Rash—Betaxolol—hypertension	8.73e-05	0.000249	CcSEcCtD
Fosamprenavir—Dermatitis—Betaxolol—hypertension	8.73e-05	0.000249	CcSEcCtD
Fosamprenavir—Headache—Betaxolol—hypertension	8.68e-05	0.000247	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Lisinopril—hypertension	8.58e-05	0.000245	CcSEcCtD
Fosamprenavir—Vomiting—Losartan—hypertension	8.58e-05	0.000245	CcSEcCtD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP4A11—hypertension	8.57e-05	0.00654	CbGpPWpGaD
Fosamprenavir—Nausea—Perindopril—hypertension	8.55e-05	0.000244	CcSEcCtD
Fosamprenavir—Hypersensitivity—Ramipril—hypertension	8.53e-05	0.000243	CcSEcCtD
Fosamprenavir—Nausea—Irbesartan—hypertension	8.52e-05	0.000243	CcSEcCtD
Fosamprenavir—Rash—Losartan—hypertension	8.51e-05	0.000243	CcSEcCtD
Fosamprenavir—Dermatitis—Losartan—hypertension	8.5e-05	0.000243	CcSEcCtD
Fosamprenavir—Headache—Losartan—hypertension	8.46e-05	0.000241	CcSEcCtD
Fosamprenavir—Nausea—Hydrochlorothiazide—hypertension	8.45e-05	0.000241	CcSEcCtD
Fosamprenavir—CYP3A4—Tryptophan metabolism—ALDH2—hypertension	8.43e-05	0.00643	CbGpPWpGaD
Fosamprenavir—Hypersensitivity—Timolol—hypertension	8.34e-05	0.000238	CcSEcCtD
Fosamprenavir—Nausea—Furosemide—hypertension	8.31e-05	0.000237	CcSEcCtD
Fosamprenavir—Asthenia—Ramipril—hypertension	8.3e-05	0.000237	CcSEcCtD
Fosamprenavir—Abdominal pain—Lisinopril—hypertension	8.3e-05	0.000237	CcSEcCtD
Fosamprenavir—Body temperature increased—Lisinopril—hypertension	8.3e-05	0.000237	CcSEcCtD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—PTGIS—hypertension	8.25e-05	0.0063	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A5—hypertension	8.25e-05	0.0063	CbGpPWpGaD
Fosamprenavir—Nausea—Betaxolol—hypertension	8.23e-05	0.000235	CcSEcCtD
Fosamprenavir—Pruritus—Ramipril—hypertension	8.19e-05	0.000234	CcSEcCtD
Fosamprenavir—Asthenia—Timolol—hypertension	8.12e-05	0.000232	CcSEcCtD
Fosamprenavir—Nausea—Losartan—hypertension	8.02e-05	0.000229	CcSEcCtD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—hypertension	8.01e-05	0.00612	CbGpPWpGaD
Fosamprenavir—Pruritus—Timolol—hypertension	8.01e-05	0.000228	CcSEcCtD
Fosamprenavir—Diarrhoea—Ramipril—hypertension	7.92e-05	0.000226	CcSEcCtD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—hypertension	7.91e-05	0.00604	CbGpPWpGaD
Fosamprenavir—Diarrhoea—Timolol—hypertension	7.74e-05	0.000221	CcSEcCtD
Fosamprenavir—Hypersensitivity—Lisinopril—hypertension	7.73e-05	0.000221	CcSEcCtD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B2—hypertension	7.72e-05	0.00589	CbGpPWpGaD
Fosamprenavir—Dizziness—Ramipril—hypertension	7.65e-05	0.000218	CcSEcCtD
Fosamprenavir—Asthenia—Lisinopril—hypertension	7.53e-05	0.000215	CcSEcCtD
Fosamprenavir—Dizziness—Timolol—hypertension	7.48e-05	0.000213	CcSEcCtD
Fosamprenavir—Pruritus—Lisinopril—hypertension	7.43e-05	0.000212	CcSEcCtD
Fosamprenavir—Vomiting—Ramipril—hypertension	7.36e-05	0.00021	CcSEcCtD
Fosamprenavir—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—hypertension	7.36e-05	0.00562	CbGpPWpGaD
Fosamprenavir—Rash—Ramipril—hypertension	7.3e-05	0.000208	CcSEcCtD
Fosamprenavir—Dermatitis—Ramipril—hypertension	7.29e-05	0.000208	CcSEcCtD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—hypertension	7.29e-05	0.00556	CbGpPWpGaD
Fosamprenavir—Headache—Ramipril—hypertension	7.25e-05	0.000207	CcSEcCtD
Fosamprenavir—Vomiting—Timolol—hypertension	7.19e-05	0.000205	CcSEcCtD
Fosamprenavir—Diarrhoea—Lisinopril—hypertension	7.18e-05	0.000205	CcSEcCtD
Fosamprenavir—Rash—Timolol—hypertension	7.13e-05	0.000203	CcSEcCtD
Fosamprenavir—Dermatitis—Timolol—hypertension	7.13e-05	0.000203	CcSEcCtD
Fosamprenavir—Headache—Timolol—hypertension	7.09e-05	0.000202	CcSEcCtD
Fosamprenavir—Dizziness—Lisinopril—hypertension	6.94e-05	0.000198	CcSEcCtD
Fosamprenavir—CYP3A4—Biological oxidations—GSTA5—hypertension	6.93e-05	0.00529	CbGpPWpGaD
Fosamprenavir—Nausea—Ramipril—hypertension	6.88e-05	0.000196	CcSEcCtD
Fosamprenavir—CYP3A4—Metapathway biotransformation—GSTA5—hypertension	6.83e-05	0.00522	CbGpPWpGaD
Fosamprenavir—Nausea—Timolol—hypertension	6.72e-05	0.000192	CcSEcCtD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—hypertension	6.68e-05	0.0051	CbGpPWpGaD
Fosamprenavir—Vomiting—Lisinopril—hypertension	6.67e-05	0.00019	CcSEcCtD
Fosamprenavir—Rash—Lisinopril—hypertension	6.62e-05	0.000189	CcSEcCtD
Fosamprenavir—Dermatitis—Lisinopril—hypertension	6.61e-05	0.000189	CcSEcCtD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—hypertension	6.6e-05	0.00504	CbGpPWpGaD
Fosamprenavir—Headache—Lisinopril—hypertension	6.58e-05	0.000188	CcSEcCtD
Fosamprenavir—CYP3A4—Biological oxidations—GSTT2—hypertension	6.57e-05	0.00501	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—hypertension	6.51e-05	0.00497	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—hypertension	6.5e-05	0.00496	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—GSTT2—hypertension	6.48e-05	0.00495	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP4F12—hypertension	6.27e-05	0.00478	CbGpPWpGaD
Fosamprenavir—Nausea—Lisinopril—hypertension	6.24e-05	0.000178	CcSEcCtD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP4F12—hypertension	6.18e-05	0.00472	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—hypertension	6.13e-05	0.00468	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—hypertension	6.05e-05	0.00462	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—CYP19A1—hypertension	6.01e-05	0.00458	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP11B1—hypertension	5.78e-05	0.00441	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—AHCY—hypertension	5.78e-05	0.00441	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP11B1—hypertension	5.7e-05	0.00435	CbGpPWpGaD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—hypertension	5.64e-05	0.0043	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GSTM5—hypertension	5.59e-05	0.00426	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—hypertension	5.52e-05	0.00422	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—EPHX2—hypertension	5.51e-05	0.00421	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—GSTM5—hypertension	5.51e-05	0.00421	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—EPHX1—hypertension	5.51e-05	0.00421	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP2J2—hypertension	5.41e-05	0.00413	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—CAT—hypertension	5.41e-05	0.00413	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—hypertension	5.35e-05	0.00408	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP2J2—hypertension	5.34e-05	0.00407	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—hypertension	4.97e-05	0.0038	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—hypertension	4.92e-05	0.00376	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—hypertension	4.86e-05	0.00371	CbGpPWpGaD
Fosamprenavir—CYP3A4—Tryptophan metabolism—CYP1A1—hypertension	4.84e-05	0.00369	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—hypertension	4.79e-05	0.00366	CbGpPWpGaD
Fosamprenavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—hypertension	4.66e-05	0.00356	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP4A11—hypertension	4.55e-05	0.00348	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—PTGIS—hypertension	4.38e-05	0.00335	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP3A5—hypertension	4.38e-05	0.00335	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP3A5—hypertension	4.32e-05	0.0033	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP11B2—hypertension	4.1e-05	0.00313	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP11B2—hypertension	4.04e-05	0.00309	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—hypertension	3.94e-05	0.003	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—hypertension	3.91e-05	0.00299	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—TBXAS1—hypertension	3.87e-05	0.00296	CbGpPWpGaD
Fosamprenavir—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—hypertension	3.86e-05	0.00295	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP2C18—hypertension	3.45e-05	0.00263	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP2C18—hypertension	3.4e-05	0.0026	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—hypertension	3.17e-05	0.00242	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—GPX3—hypertension	3.02e-05	0.0023	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—ALDH2—hypertension	2.93e-05	0.00224	CbGpPWpGaD
Fosamprenavir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypertension	2.92e-05	0.00223	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP11A1—hypertension	2.84e-05	0.00217	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP11A1—hypertension	2.8e-05	0.00214	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GSTT1—hypertension	2.79e-05	0.00213	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GCLC—hypertension	2.76e-05	0.00211	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP17A1—hypertension	2.64e-05	0.00202	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—PTGS1—hypertension	2.62e-05	0.002	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP17A1—hypertension	2.61e-05	0.00199	CbGpPWpGaD
Fosamprenavir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypertension	2.37e-05	0.00181	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP19A1—hypertension	2.09e-05	0.0016	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP19A1—hypertension	2.06e-05	0.00157	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—COMT—hypertension	1.94e-05	0.00148	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—COMT—hypertension	1.92e-05	0.00146	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—GSTM1—hypertension	1.78e-05	0.00136	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—GSTM1—hypertension	1.75e-05	0.00134	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—CYP1A1—hypertension	1.69e-05	0.00129	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—FAH—hypertension	1.66e-05	0.00127	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metapathway biotransformation—CYP1A1—hypertension	1.66e-05	0.00127	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—QDPR—hypertension	1.26e-05	0.000962	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HAS2—hypertension	1.26e-05	0.000962	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HAS3—hypertension	1.26e-05	0.000962	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PNMT—hypertension	1.26e-05	0.000962	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HYAL2—hypertension	1.26e-05	0.000962	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HAS1—hypertension	1.26e-05	0.000962	CbGpPWpGaD
Fosamprenavir—CYP3A4—Biological oxidations—POMC—hypertension	1.26e-05	0.000959	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GSTA5—hypertension	1.19e-05	0.000905	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HYAL1—hypertension	1.12e-05	0.000858	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GSTT2—hypertension	1.12e-05	0.000858	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—MDH1—hypertension	1.12e-05	0.000858	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CDO1—hypertension	1.12e-05	0.000858	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CPS1—hypertension	1.12e-05	0.000858	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GCH1—hypertension	1.07e-05	0.000818	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP4F12—hypertension	1.07e-05	0.000818	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PLCD1—hypertension	1.03e-05	0.000784	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP11B1—hypertension	9.89e-06	0.000755	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—AHCY—hypertension	9.89e-06	0.000755	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—DBH—hypertension	9.55e-06	0.000729	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GBA—hypertension	9.55e-06	0.000729	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—EPHX2—hypertension	9.55e-06	0.000729	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GSTM5—hypertension	9.55e-06	0.000729	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALOX12—hypertension	9.55e-06	0.000729	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP2J2—hypertension	9.25e-06	0.000706	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ARG1—hypertension	8.98e-06	0.000686	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GLS2—hypertension	8.98e-06	0.000686	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—DECR1—hypertension	8.98e-06	0.000686	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—COX5B—hypertension	8.98e-06	0.000686	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALAD—hypertension	8.51e-06	0.00065	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALDH7A1—hypertension	8.12e-06	0.00062	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PLCE1—hypertension	8.12e-06	0.00062	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—STS—hypertension	8.12e-06	0.00062	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CBS—hypertension	7.79e-06	0.000594	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP4A11—hypertension	7.79e-06	0.000594	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ARG2—hypertension	7.79e-06	0.000594	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—XDH—hypertension	7.64e-06	0.000583	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP3A5—hypertension	7.5e-06	0.000572	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SLC5A2—hypertension	7.5e-06	0.000572	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PTGIS—hypertension	7.5e-06	0.000572	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—UCP3—hypertension	7.24e-06	0.000553	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—TPH1—hypertension	7.24e-06	0.000553	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—UCP2—hypertension	7.24e-06	0.000553	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ABCC1—hypertension	7.24e-06	0.000553	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HSD11B1—hypertension	7.24e-06	0.000553	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALAS1—hypertension	7.01e-06	0.000535	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SLC2A3—hypertension	7.01e-06	0.000535	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP11B2—hypertension	7.01e-06	0.000535	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HSD3B1—hypertension	6.91e-06	0.000527	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ADA—hypertension	6.91e-06	0.000527	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—AQP1—hypertension	6.81e-06	0.00052	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—FADS1—hypertension	6.81e-06	0.00052	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CA9—hypertension	6.62e-06	0.000505	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—TBXAS1—hypertension	6.62e-06	0.000505	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALOX15—hypertension	6.45e-06	0.000493	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALOX5AP—hypertension	6.45e-06	0.000493	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HADHA—hypertension	6.3e-06	0.000481	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—LHB—hypertension	6.3e-06	0.000481	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—LPA—hypertension	6.16e-06	0.00047	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—KCNJ11—hypertension	6.16e-06	0.00047	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HSD3B2—hypertension	6.16e-06	0.00047	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—LRP2—hypertension	5.9e-06	0.00045	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP2C18—hypertension	5.9e-06	0.00045	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HSPG2—hypertension	5.68e-06	0.000434	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALOX5—hypertension	5.49e-06	0.000419	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GLP1R—hypertension	5.49e-06	0.000419	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALDH2—hypertension	5.02e-06	0.000383	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HBA1—hypertension	4.89e-06	0.000373	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP11A1—hypertension	4.86e-06	0.000371	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SLC9A1—hypertension	4.77e-06	0.000364	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GSTT1—hypertension	4.77e-06	0.000364	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GCLC—hypertension	4.72e-06	0.00036	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CETP—hypertension	4.72e-06	0.00036	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP17A1—hypertension	4.52e-06	0.000345	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ENO1—hypertension	4.47e-06	0.000341	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PTGS1—hypertension	4.47e-06	0.000341	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CTGF—hypertension	4.31e-06	0.000329	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HMGCR—hypertension	4.27e-06	0.000326	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GOT2—hypertension	4.27e-06	0.000326	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ADRA2A—hypertension	4.18e-06	0.000319	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—TH—hypertension	3.91e-06	0.000298	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CALM2—hypertension	3.9e-06	0.000297	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—SLC2A4—hypertension	3.8e-06	0.00029	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GCG—hypertension	3.8e-06	0.00029	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GOT1—hypertension	3.68e-06	0.000281	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—STK11—hypertension	3.58e-06	0.000273	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP19A1—hypertension	3.58e-06	0.000273	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—COMT—hypertension	3.32e-06	0.000254	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GNB3—hypertension	3.28e-06	0.00025	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PPARGC1A—hypertension	3.28e-06	0.00025	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—HMOX1—hypertension	3.26e-06	0.000249	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CAT—hypertension	3.22e-06	0.000246	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GNAS—hypertension	3.19e-06	0.000244	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—APOB—hypertension	3.13e-06	0.000239	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GSTM1—hypertension	3.04e-06	0.000232	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—LPL—hypertension	2.98e-06	0.000228	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ADCY5—hypertension	2.92e-06	0.000223	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—GPX1—hypertension	2.91e-06	0.000222	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PRKCA—hypertension	2.88e-06	0.00022	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CYP1A1—hypertension	2.88e-06	0.00022	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CD36—hypertension	2.84e-06	0.000216	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—MTHFR—hypertension	2.69e-06	0.000205	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PPARA—hypertension	2.64e-06	0.000201	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—AGT—hypertension	2.55e-06	0.000195	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CALM1—hypertension	2.51e-06	0.000192	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—APOE—hypertension	2.5e-06	0.000191	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—CAV1—hypertension	2.48e-06	0.000189	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—APOA1—hypertension	2.47e-06	0.000189	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PPARG—hypertension	2.18e-06	0.000166	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—POMC—hypertension	2.15e-06	0.000164	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—INS—hypertension	2.14e-06	0.000163	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—ALB—hypertension	1.96e-06	0.00015	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—NOS3—hypertension	1.87e-06	0.000143	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PIK3R1—hypertension	1.87e-06	0.000143	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PTGS2—hypertension	1.71e-06	0.000131	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—PTEN—hypertension	1.49e-06	0.000114	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—EP300—hypertension	1.43e-06	0.000109	CbGpPWpGaD
Fosamprenavir—CYP3A4—Metabolism—AKT1—hypertension	8.61e-07	6.58e-05	CbGpPWpGaD
